01 1Sinopharm Weiqida Pharmaceutical Co Ltd
01 1AMOXICILLIN TRIHYDRATE (COMPACTED POWDER)
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-16
Pay. Date : 2022-03-07
DMF Number : 36698
Submission : 2022-02-13
Status : Active
Type : II
20
Sinopharm Weiqida Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMOXICILLIN TRIHYDRATE (COMPACTED POWDER), with a corresponding US DMF Number 36698.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 16, 2022, and payment made on March 07, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
